Header Logo

Connection

Paul Daniel to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Paul Daniel has written about Antibodies, Monoclonal, Humanized.
Paul Daniel
Connection Strength
0.019
Antibodies, Monoclonal, Humanized
  1. Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE, Kim IK. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011 Jan; 118(1):111-8.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.